Ground Swell Capital’s GSK GSK Stock Holding History

Ground Swell Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,978	Closed	-$270K	–	189
2025 Q1	$270K	Buy	+6,978	New	+$255K	0.58%	67
2014 Q3	$10K	Buy	+173	New	+$10.6K	0.02%	952

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Ground Swell Capital's GSK Position: Q2 2025 in Review

Ground Swell Capital sold out of GSK (GSK) in Q2 2025, closing a stake of 6,978 shares — an estimated $270K sold.

Ground Swell Capital first reported a position in GSK in Q3 2014 and held it in 2 quarters. The position peaked at $270K in Q1 2025. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Ground Swell Capital reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Ground Swell Capital sold 6,978 GSK shares in Q2 2025, an estimated $270K.
Ground Swell Capital first reported a position in GSK in Q3 2014 and held it in 2 quarters.
Ground Swell Capital's GSK position peaked at $270K in Q1 2025.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Ground Swell Capital's 13F filing for Q2 2025, filed 31 Jul 2025.